MX2017014666A - Metodos de inmunización contra clostridium difficile. - Google Patents
Metodos de inmunización contra clostridium difficile.Info
- Publication number
- MX2017014666A MX2017014666A MX2017014666A MX2017014666A MX2017014666A MX 2017014666 A MX2017014666 A MX 2017014666A MX 2017014666 A MX2017014666 A MX 2017014666A MX 2017014666 A MX2017014666 A MX 2017014666A MX 2017014666 A MX2017014666 A MX 2017014666A
- Authority
- MX
- Mexico
- Prior art keywords
- difficile
- methods
- cdt
- purified
- toxin
- Prior art date
Links
- 241000193163 Clostridioides difficile Species 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 3
- 230000003053 immunization Effects 0.000 title abstract 2
- 239000003053 toxin Substances 0.000 abstract 2
- 231100000765 toxin Toxicity 0.000 abstract 2
- 108700012359 toxins Proteins 0.000 abstract 2
- 241000193403 Clostridium Species 0.000 abstract 1
- 101710084578 Short neurotoxin 1 Proteins 0.000 abstract 1
- 101710182223 Toxin B Proteins 0.000 abstract 1
- 101710182532 Toxin a Proteins 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La descripción se relaciona generalmente al campo de vacunación terapéutica y/o protectora contra Clostridium difficile (C. difficile). Más específicamente, se relaciona a métodos para inmunizar un hospedero contra cepas C. difficile que expresan toxina binaria C. difficile (CDT) y cepas que no expresan CDT. Estos métodos involucran la administración a un hospedero de una composición inmunogénica que comprende Toxina A C. difficile purificada inactivada y Toxina B purificada. Las toxinas C. difficile purificadas se pueden derivar de una cepa C. difficile que no expresa CDT.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562162357P | 2015-05-15 | 2015-05-15 | |
| PCT/US2016/032568 WO2016187073A1 (en) | 2015-05-15 | 2016-05-14 | Methods for immunizing against clostridium difficile |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017014666A true MX2017014666A (es) | 2018-02-09 |
Family
ID=56101790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017014666A MX2017014666A (es) | 2015-05-15 | 2016-05-14 | Metodos de inmunización contra clostridium difficile. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20180110849A1 (es) |
| EP (1) | EP3294330A1 (es) |
| JP (1) | JP2018521967A (es) |
| KR (1) | KR20180011784A (es) |
| CN (1) | CN107847576A (es) |
| AU (1) | AU2016263203A1 (es) |
| BR (1) | BR112017024443A2 (es) |
| CA (1) | CA2986025A1 (es) |
| IL (1) | IL255592A (es) |
| MX (1) | MX2017014666A (es) |
| WO (1) | WO2016187073A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018383764A1 (en) * | 2017-12-13 | 2020-07-02 | Texas Tech University System | Pheromone compositions for stimulating early onset of estrus and reducing labor needs in breeding peri-pubertal suids and methods of use |
| CN113329766A (zh) * | 2018-11-16 | 2021-08-31 | 马特里瓦克斯公司 | 艰难梭菌多组分疫苗 |
| USD1070876S1 (en) | 2022-07-14 | 2025-04-15 | Samsung Electronics Co., Ltd. | Display screen or portion thereof with transitional graphical user interface |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6669520B2 (en) | 2001-09-19 | 2003-12-30 | United Microelectronics Corp. | Method of fabricating an LC panel |
| MX2010001054A (es) | 2007-07-26 | 2010-04-21 | Sanofi Pasteur Ltd | Composiciones adyuvantes antigenicas y metodos. |
| BRPI0816790A8 (pt) | 2007-09-14 | 2017-05-16 | Sanofi Pasteur Biologics Co | Composições farmacêuticas contendo toxóides a e b de clostridium difficile |
| AR089797A1 (es) | 2012-01-27 | 2014-09-17 | Merck Sharp & Dohme | Vacunas contra clostridum difficile que comprenden toxinas recombinantes |
| GB201206070D0 (en) * | 2012-04-04 | 2012-05-16 | Health Prot Agency | Clostridium difficile antigens |
| SG11201507608PA (en) * | 2013-03-15 | 2015-10-29 | Sanofi Pasteur Inc | Toxoid, compositions and related methods |
-
2016
- 2016-05-14 MX MX2017014666A patent/MX2017014666A/es unknown
- 2016-05-14 JP JP2017559527A patent/JP2018521967A/ja active Pending
- 2016-05-14 EP EP16727261.6A patent/EP3294330A1/en not_active Withdrawn
- 2016-05-14 KR KR1020177036313A patent/KR20180011784A/ko not_active Withdrawn
- 2016-05-14 CA CA2986025A patent/CA2986025A1/en not_active Abandoned
- 2016-05-14 AU AU2016263203A patent/AU2016263203A1/en not_active Abandoned
- 2016-05-14 WO PCT/US2016/032568 patent/WO2016187073A1/en not_active Ceased
- 2016-05-14 US US15/573,351 patent/US20180110849A1/en not_active Abandoned
- 2016-05-14 CN CN201680041646.1A patent/CN107847576A/zh active Pending
- 2016-05-14 BR BR112017024443A patent/BR112017024443A2/pt not_active IP Right Cessation
-
2017
- 2017-11-12 IL IL255592A patent/IL255592A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL255592A (en) | 2018-01-31 |
| JP2018521967A (ja) | 2018-08-09 |
| US20180110849A1 (en) | 2018-04-26 |
| KR20180011784A (ko) | 2018-02-02 |
| EP3294330A1 (en) | 2018-03-21 |
| CN107847576A (zh) | 2018-03-27 |
| AU2016263203A1 (en) | 2017-11-30 |
| BR112017024443A2 (pt) | 2018-10-23 |
| CA2986025A1 (en) | 2016-11-24 |
| WO2016187073A1 (en) | 2016-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX351074B (es) | Vacunas contra clostridium difficile que comprenden toxinas recombinantes. | |
| MX2018004598A (es) | Cepas vacunales recombinantes de listeria y métodos para usar las mismas en la inmunoterapia contra el cáncer. | |
| EP4344741A3 (en) | Aav vectors targeted to the central nervous system | |
| MX2017004897A (es) | Cepas vacunales recombinantes de listeria y metodos para usar las mismas en la inmunoterapia contra el cancer. | |
| AU2015296298A8 (en) | Flagellin-based agents and uses including effective vaccination | |
| CL2019003805A1 (es) | Composiciones inmunógenas de senecavirus a y métodos de éstas. | |
| JO3600B1 (ar) | لقاحات مؤتلفة ل fmdv و استخداماتها | |
| PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
| WO2013106834A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| MX2016009072A (es) | Fusion de antigenos micobacterianos heterooligomericos. | |
| MX2016011537A (es) | Metodos y composiciones para aumentar una relacion de celulas t efectoras con respecto a las celulas t reguladoras. | |
| MY191539A (en) | Streptococcal vaccine | |
| MX2021013109A (es) | Proceso de preparacion de una vacuna tetravalente atenuada contra el virus del dengue. | |
| NZ715459A (en) | A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same | |
| WO2019028396A8 (en) | Induction of protective immunity against antigens | |
| MX2018015506A (es) | Vacuna contra virus de bronquitis infecciosa. | |
| PH12021551816A1 (en) | Inactivated apxia, apxiia and apxiiia toxins | |
| MX2019011026A (es) | Nueva vacuna de adn dirigida a pd-l1 para inmunoterapia de cancer. | |
| MX2022013912A (es) | Procedimientos novedosos para inducir una respuesta inmunitaria. | |
| MX2017014666A (es) | Metodos de inmunización contra clostridium difficile. | |
| PH12017501795A1 (en) | Pestivirus vaccines for congenital tremors | |
| PH12017500419B1 (en) | Recoded arbovirus and vaccines | |
| MX2016002823A (es) | Metodos y composiciones para vacunas vectorizadas virales. | |
| MX2021015026A (es) | Peptido derivado de urlc10 y vacuna que lo contiene. | |
| TW201613952A (en) | Cdca1-derived peptide and vaccine containing same |